 <h1>Esomeprazole / naproxen Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of esomeprazole/naproxen include:</b> increased liver enzymes. <b>Other side effects include:</b> constipation.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to esomeprazole / naproxen: oral tablet delayed release</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet, Delayed Release)</p><p>There is an increased risk of serious and potentially fatal cardiovascular (CV) thrombotic events, myocardial infarction, and stroke with NSAID use, especially with longer durations, a history of CV disease, or risk factors for CV disease. NSAIDs increase the risk of serious and sometimes fatal gastrointestinal (GI) adverse events, which can include bleeding, ulceration, and perforation of the stomach or intestines. The elderly are at increased risk. These GI events can occur at any time without warning. This drug is contraindicated for the treatment of perioperative pain related to CABG surgery.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, esomeprazole/naproxen may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking esomeprazole / naproxen:</p><p>
<i>More common</i>
</p><ul>
<li>Blistering, peeling, or reddening of the skin</li>
<li>burning feeling in the chest or stomach</li>
<li>indigestion</li>
<li>loss of appetite</li>
<li>nausea</li>
<li>stomach bloating, cramping, or pain</li>
<li>tenderness in the stomach area</li>
<li>upper abdominal or stomach pain</li>
<li>upset stomach</li>
<li>vomiting</li>
<li>weight loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bladder pain</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>bloody or cloudy urine</li>
<li>bloody stools</li>
<li>chest pain</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty with breathing</li>
<li>difficulty with moving</li>
<li>difficulty with swallowing</li>
<li>frequent urge to urinate</li>
<li>full or bloated feeling</li>
<li>heartburn</li>
<li>lower back or side pain</li>
<li>muscle pain or stiffness</li>
<li>pain in the joints</li>
<li>pain or burning in the throat</li>
<li>pressure in the stomach</li>
<li>rapid weight gain</li>
<li>sores, ulcers, or white spots on the lips or tongue or inside the mouth</li>
<li>stomach discomfort</li>
<li>swelling of the abdominal or stomach area</li>
<li>tingling of the hands or feet</li>
<li>unusual weight gain or loss</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Drowsiness</li>
<li>mood or mental changes</li>
<li>muscle spasms (tetany) or twitching</li>
<li>seizures</li>
<li>trembling</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of esomeprazole / naproxen may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Belching</li>
<li>diarrhea</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Body aches or pain</li>
<li>change in taste</li>
<li>chills</li>
<li>cough</li>
<li>cough producing mucus</li>
<li>difficulty having a bowel movement </li>
<li>ear congestion</li>
<li>excess air or gas in the stomach or bowels</li>
<li>fever</li>
<li>headache</li>
<li>loss of taste</li>
<li>loss of voice</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>passing gas</li>
<li>sneezing</li>
<li>sore throat</li>
<li>stuffy or runny nose</li>
</ul><p>
<!-- end oral tablet delayed release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to esomeprazole / naproxen: oral delayed release tablet</i></p><h3>General</h3><p>Naproxen:</p>
<p><b>Postmarketing reports</b>: Anaphylactic reactions, angioneurotic edema, menstrual disorders, pyrexia (chills and fever), hearing impairment<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Esomeprazole-naproxen was reported to cause fewer NSAID-related upper gastrointestinal adverse events (e.g., duodenal ulcer) (53.3%) compared to enteric coated naproxen taken as monotherapy (70.4%).</p>
<p></p>
<p>NSAIDs, including naproxen, have been reported to lead to upper gastrointestinal ulcers and gross bleeding or perforation in approximately 1% of patient treated for 3 to 6 months, and about 2% to 4% of patients treated for one year.<sup>[Ref]</sup></p><p>Esomeprazole-naproxen:</p>
<p><b>Very common</b> (10% or more): Gastritis erosive (up to 38%), dyspepsia (up to 27%), gastritis (up to 17%)</p>
<p><b>Common</b> (1% to 10%): Diarrhea, gastric ulcer, upper abdominal pain, nausea, hiatus hernia, abdominal distension, flatulence, esophagitis, constipation, abdominal pain, duodenitis, erosive duodenitis, lower abdominal pain, hemorrhagic gastritis, gastroesophageal reflux disease, duodenal ulcer, erosive esophagitis</p>
<p><b>Postmarketing reports</b>: Hematochezia</p>
<p></p>
<p>Esomeprazole:</p>
<p><b>Postmarketing reports</b>: Pancreatitis; stomatitis; microscopic colitis, GI candidiasis, Clostridium difficile associated diarrhea</p>
<p><b>Uncommon</b> (0.1% to 1%): Dyspepsia, dysphagia, dysplasia GI, epigastric pain, eructation, esophageal disorder, gastroenteritis, GI hemorrhage, GI symptoms not otherwise specified, hiccup, melena, mouth disorder, pharynx disorder, rectal disorder, serum gastrin increased, tongue disorder, tongue edema, ulcerative stomatitis, vomiting, abdomen enlarged, Clostridium difficile associated diarrhea</p>
<p></p>
<p>Naproxen:</p>
<p><b>Common</b> (1% to 10%): Heartburn, nausea, dyspepsia, stomatitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Pancreatitis, melena</p>
<p><b>Postmarketing reports</b>: Inflammation, bleeding (sometimes fatal, particularly in the elderly), ulceration, and obstruction of the upper or lower gastrointestinal tract, esophagitis, stomatitis, hematemesis, colitis, exacerbation of inflammatory bowel disease (ulcerative colitis, Crohn's disease)<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Esomeprazole-naproxen:</p>
<p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p></p>
<p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Vaginitis, cystitis, dysuria, fungal infection, micturition frequency, moniliasis, genital moniliasis<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Esomeprazole-naproxen:</p>
<p><b>Common</b> (1% to 10%): Upper respiratory tract infection, bronchitis, sinusitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Nasopharyngitis, cough</p>
<p></p>
<p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Chest pain, substernal chest pain, asthma aggravated, coughing, dyspnea, larynx edema, pharyngitis, rhinitis, sinusitis</p>
<p><b>Postmarketing reports</b>: Bronchospasm</p>
<p></p>
<p>Naproxen:</p>
<p><b>Common</b> (1% to 10%): Dyspnea</p>
<p><b>Postmarketing reports</b>: Eosinophilic pneumonitis, asthma<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Esomeprazole-naproxen:</p>
<p><b>Common</b> (1% to 10%): Arthralgia</p>
<p><b>Postmarketing reports</b>: Joint swelling, muscle spasms</p>
<p></p>
<p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Arthralgia, arthritis aggravated, arthropathy, cramps, fibromyalgia syndrome, hernia, polymyalgia rheumatica, back pain</p>
<p><b>Postmarketing reports</b>: Muscular weakness, myalgia, bone fracture</p>
<p></p>
<p>Naproxen:</p>
<p><b>Postmarketing reports</b>: Myalgia, muscle weakness<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Clinical trials and epidemiological data have suggested a small increased risk of arterial thrombotic events (e.g., myocardial infarction or stroke) with the use of "coxibs" or some NSAIDs, especially when used at high doses and for long treatment durations.  Although naproxen doses of 1000 mg per day may be associated with a lower risk than COX-2 selective inhibitors, a small risk cannot be excluded.<sup>[Ref]</sup></p><p>Esomeprazole-naproxen:</p>
<p><b>Frequency not reported</b>: Peripheral edema, arrhythmia, palpitations, myocardial infarction, congestive heart failure, hypertension, syncope</p>
<p></p>
<p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Flushing, hypertension, tachycardia</p>
<p></p>
<p>Naproxen:</p>
<p><b>Common</b> (1% to 10%): Palpitations</p>
<p><b>Postmarketing reports</b>: Congestive heart failure, vasculitis, hypertension, pulmonary edema<sup>[Ref]</sup></p><h3>Other</h3><p>Esomeprazole-naproxen:</p>
<p><b>Postmarketing reports</b>: Gait disturbances</p>
<p></p>
<p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Fatigue, fever, flu-like disorder, generalized edema, , malaise, pain, rigors, earache, tinnitus, vertigo, asthenia, dysmenorrhea, menstrual disorder, hot flushes</p>
<p><b>Postmarketing reports</b>: GI candidiasis, gynecomastia</p>
<p></p>
<p>Naproxen:</p>
<p><b>Common</b> (1% to 10%): Vertigo, tinnitus, hearing disturbances, thirst</p>
<p><b>Postmarketing reports</b>: Angioneurotic edema, menstrual disorders, hearing impairment, infertility, papillitis, malaise, aseptic meningitis<sup>[Ref]</sup></p><h3>Renal</h3><p>Esomeprazole-naproxen:</p>
<p><b>Postmarketing reports</b>: Renal tubular necrosis</p>
<p></p>
<p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal urine, albuminuria, hematuria, polyuria, glycosuria, hyperuricemia</p>
<p><b>Postmarketing reports</b>: Interstitial nephritis</p>
<p></p>
<p>Naproxen:</p>
<p><b>Postmarketing reports</b>: Glomerular nephritis, hematuria, hyperkalemia, interstitial nephritis, nephrotic syndrome, renal disease, renal failure, renal papillary necrosis, raised serum creatinine<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Acne, angioedema, dermatitis, pruritus, pruritus ani, rash, rash erythematous, rash maculo-papular, skin inflammation, sweating increased, urticaria, facial edema</p>
<p><b>Postmarketing reports</b>: Alopecia, erythema multiforme, hyperhidrosis, photosensitivity, Stevens-Johnson syndrome, toxic epidermal necrolysis (some fatal)</p>
<p></p>
<p>Naproxen:</p>
<p><b>Common</b> (1% to 10%): Pruritus, skin eruptions, ecchymoses, sweating, purpura</p>
<p><b>Uncommon</b> (0.1% to 1%): Skin rashes</p>
<p><b>Postmarketing reports</b>: Alopecia, urticaria, skin rashes, toxic epidermal necrolysis, erythema multiforme, erythema nodosum, fixed drug eruption, lichen planus, pustular reaction, systemic lupus erythematosus, bullous reactions, including Stevens-Johnson syndrome, photosensitive dermatitis, photosensitivity reactions, including rare cases resembling porphyria cutanea tarda (pseudoporphyria) or epidermolysis bullosa<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Goiter<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Anemia, anemia hypochromic, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia</p>
<p><b>Postmarketing reports</b>: Agranulocytosis, pancytopenia</p>
<p></p>
<p>Naproxen:</p>
<p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia, agranulocytosis</p>
<p><b>Postmarketing reports</b>: Eosinophilia, leukopenia, thrombocytopenia, agranulocytosis, granulocytopenia, hemolytic anemia, aplastic anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Bilirubinemia, abnormal hepatic function, SGOT increased, SGPT increased</p>
<p><b>Postmarketing reports</b>: Hepatic failure, hepatitis with or without jaundice</p>
<p></p>
<p>Naproxen:</p>
<p><b>Uncommon</b> (0.1% to 1%): Jaundice</p>
<p><b>Postmarketing reports</b>: Abnormal liver function tests, hepatitis (some cases have been fatal)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Allergic reaction</p>
<p><b>Postmarketing reports</b>: Anaphylactic reaction/shock<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Hyponatremia, increased alkaline phosphatase, vitamin B12 deficiency, weight increase, weight decrease, anorexia, appetite increased</p>
<p><b>Postmarketing reports</b>: Hypomagnesemia with or without hypocalcemia</p>
<p></p>
<p>Naproxen:</p>
<p><b>Postmarketing reports</b>: Hyperglycemia, hypoglycemia<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypertonia, nervousness, hypoesthesia, impotence, insomnia, migraine, migraine aggravated, paresthesia, somnolence, tremor, taste loss</p>
<p><b>Postmarketing reports</b>: Hepatic encephalopathy, taste disturbance</p>
<p></p>
<p>Naproxen:</p>
<p><b>Common</b> (1% to 10%): Headache, dysgeusia, drowsiness, lightheadedness</p>
<p><b>Uncommon</b> (0.1% to 1%): Inability to concentrate</p>
<p><b>Postmarketing reports</b>: Cognitive dysfunction, convulsions<sup>[Ref]</sup></p><h3>Ocular</h3><p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Visual field defect, conjunctivitis, vision abnormal</p>
<p><b>Postmarketing reports</b>: Blurred vision</p>
<p></p>
<p>Naproxen:</p>
<p><b>Common</b> (1% to 10%): Visual disturbances</p>
<p><b>Postmarketing reports</b>: Corneal opacity, papillitis, retrobulbar optic neuritis, papilledema<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Esomeprazole:</p>
<p><b>Uncommon</b> (0.1% to 1%): Sleep disorder, apathy, aggravated depression, confusion</p>
<p><b>Postmarketing reports</b>: Aggression, agitation, depression, hallucination</p>
<p></p>
<p>Naproxen:</p>
<p><b>Postmarketing reports</b>: Depression, dream abnormalities, insomnia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. VIMOVO (esomeprazole-naproxen)." Astra-Zeneca Pharmaceuticals, Wilmington, DE. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about esomeprazole / naproxen</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>41 Reviews</li>
<li>Drug class: Nonsteroidal anti-inflammatory drugs</li>
<li>FDA Alerts (4)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Naproxen and esomeprazole &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Vimovo</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Ankylosing Spondylitis</li>
<li>NSAID-Induced Ulcer Prophylaxis</li>
<li>Osteoarthritis</li>
<li>Rheumatoid Arthritis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to esomeprazole / naproxen: oral delayed release tablet</i></p><h3>General</h3><p>Naproxen:</p><p><b>Postmarketing reports</b>: Anaphylactic reactions, angioneurotic edema, menstrual disorders, pyrexia (chills and fever), hearing impairment<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Esomeprazole-naproxen was reported to cause fewer NSAID-related upper gastrointestinal adverse events (e.g., duodenal ulcer) (53.3%) compared to enteric coated naproxen taken as monotherapy (70.4%).</p><p></p><p>NSAIDs, including naproxen, have been reported to lead to upper gastrointestinal ulcers and gross bleeding or perforation in approximately 1% of patient treated for 3 to 6 months, and about 2% to 4% of patients treated for one year.<sup>[Ref]</sup></p><p>Esomeprazole-naproxen:</p><p><b>Very common</b> (10% or more): Gastritis erosive (up to 38%), dyspepsia (up to 27%), gastritis (up to 17%)</p><p><b>Common</b> (1% to 10%): Diarrhea, gastric ulcer, upper abdominal pain, nausea, hiatus hernia, abdominal distension, flatulence, esophagitis, constipation, abdominal pain, duodenitis, erosive duodenitis, lower abdominal pain, hemorrhagic gastritis, gastroesophageal reflux disease, duodenal ulcer, erosive esophagitis</p><p><b>Postmarketing reports</b>: Hematochezia</p><p></p><p>Esomeprazole:</p><p><b>Postmarketing reports</b>: Pancreatitis; stomatitis; microscopic colitis, GI candidiasis, Clostridium difficile associated diarrhea</p><p><b>Uncommon</b> (0.1% to 1%): Dyspepsia, dysphagia, dysplasia GI, epigastric pain, eructation, esophageal disorder, gastroenteritis, GI hemorrhage, GI symptoms not otherwise specified, hiccup, melena, mouth disorder, pharynx disorder, rectal disorder, serum gastrin increased, tongue disorder, tongue edema, ulcerative stomatitis, vomiting, abdomen enlarged, Clostridium difficile associated diarrhea</p><p></p><p>Naproxen:</p><p><b>Common</b> (1% to 10%): Heartburn, nausea, dyspepsia, stomatitis</p><p><b>Uncommon</b> (0.1% to 1%): Pancreatitis, melena</p><p><b>Postmarketing reports</b>: Inflammation, bleeding (sometimes fatal, particularly in the elderly), ulceration, and obstruction of the upper or lower gastrointestinal tract, esophagitis, stomatitis, hematemesis, colitis, exacerbation of inflammatory bowel disease (ulcerative colitis, Crohn's disease)<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Esomeprazole-naproxen:</p><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p></p><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Vaginitis, cystitis, dysuria, fungal infection, micturition frequency, moniliasis, genital moniliasis<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Esomeprazole-naproxen:</p><p><b>Common</b> (1% to 10%): Upper respiratory tract infection, bronchitis, sinusitis</p><p><b>Uncommon</b> (0.1% to 1%): Nasopharyngitis, cough</p><p></p><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Chest pain, substernal chest pain, asthma aggravated, coughing, dyspnea, larynx edema, pharyngitis, rhinitis, sinusitis</p><p><b>Postmarketing reports</b>: Bronchospasm</p><p></p><p>Naproxen:</p><p><b>Common</b> (1% to 10%): Dyspnea</p><p><b>Postmarketing reports</b>: Eosinophilic pneumonitis, asthma<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Esomeprazole-naproxen:</p><p><b>Common</b> (1% to 10%): Arthralgia</p><p><b>Postmarketing reports</b>: Joint swelling, muscle spasms</p><p></p><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Arthralgia, arthritis aggravated, arthropathy, cramps, fibromyalgia syndrome, hernia, polymyalgia rheumatica, back pain</p><p><b>Postmarketing reports</b>: Muscular weakness, myalgia, bone fracture</p><p></p><p>Naproxen:</p><p><b>Postmarketing reports</b>: Myalgia, muscle weakness<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Clinical trials and epidemiological data have suggested a small increased risk of arterial thrombotic events (e.g., myocardial infarction or stroke) with the use of "coxibs" or some NSAIDs, especially when used at high doses and for long treatment durations.  Although naproxen doses of 1000 mg per day may be associated with a lower risk than COX-2 selective inhibitors, a small risk cannot be excluded.<sup>[Ref]</sup></p><p>Esomeprazole-naproxen:</p><p><b>Frequency not reported</b>: Peripheral edema, arrhythmia, palpitations, myocardial infarction, congestive heart failure, hypertension, syncope</p><p></p><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Flushing, hypertension, tachycardia</p><p></p><p>Naproxen:</p><p><b>Common</b> (1% to 10%): Palpitations</p><p><b>Postmarketing reports</b>: Congestive heart failure, vasculitis, hypertension, pulmonary edema<sup>[Ref]</sup></p><h3>Other</h3><p>Esomeprazole-naproxen:</p><p><b>Postmarketing reports</b>: Gait disturbances</p><p></p><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Fatigue, fever, flu-like disorder, generalized edema, , malaise, pain, rigors, earache, tinnitus, vertigo, asthenia, dysmenorrhea, menstrual disorder, hot flushes</p><p><b>Postmarketing reports</b>: GI candidiasis, gynecomastia</p><p></p><p>Naproxen:</p><p><b>Common</b> (1% to 10%): Vertigo, tinnitus, hearing disturbances, thirst</p><p><b>Postmarketing reports</b>: Angioneurotic edema, menstrual disorders, hearing impairment, infertility, papillitis, malaise, aseptic meningitis<sup>[Ref]</sup></p><h3>Renal</h3><p>Esomeprazole-naproxen:</p><p><b>Postmarketing reports</b>: Renal tubular necrosis</p><p></p><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal urine, albuminuria, hematuria, polyuria, glycosuria, hyperuricemia</p><p><b>Postmarketing reports</b>: Interstitial nephritis</p><p></p><p>Naproxen:</p><p><b>Postmarketing reports</b>: Glomerular nephritis, hematuria, hyperkalemia, interstitial nephritis, nephrotic syndrome, renal disease, renal failure, renal papillary necrosis, raised serum creatinine<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Acne, angioedema, dermatitis, pruritus, pruritus ani, rash, rash erythematous, rash maculo-papular, skin inflammation, sweating increased, urticaria, facial edema</p><p><b>Postmarketing reports</b>: Alopecia, erythema multiforme, hyperhidrosis, photosensitivity, Stevens-Johnson syndrome, toxic epidermal necrolysis (some fatal)</p><p></p><p>Naproxen:</p><p><b>Common</b> (1% to 10%): Pruritus, skin eruptions, ecchymoses, sweating, purpura</p><p><b>Uncommon</b> (0.1% to 1%): Skin rashes</p><p><b>Postmarketing reports</b>: Alopecia, urticaria, skin rashes, toxic epidermal necrolysis, erythema multiforme, erythema nodosum, fixed drug eruption, lichen planus, pustular reaction, systemic lupus erythematosus, bullous reactions, including Stevens-Johnson syndrome, photosensitive dermatitis, photosensitivity reactions, including rare cases resembling porphyria cutanea tarda (pseudoporphyria) or epidermolysis bullosa<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Goiter<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Anemia, anemia hypochromic, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia</p><p><b>Postmarketing reports</b>: Agranulocytosis, pancytopenia</p><p></p><p>Naproxen:</p><p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia, agranulocytosis</p><p><b>Postmarketing reports</b>: Eosinophilia, leukopenia, thrombocytopenia, agranulocytosis, granulocytopenia, hemolytic anemia, aplastic anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Bilirubinemia, abnormal hepatic function, SGOT increased, SGPT increased</p><p><b>Postmarketing reports</b>: Hepatic failure, hepatitis with or without jaundice</p><p></p><p>Naproxen:</p><p><b>Uncommon</b> (0.1% to 1%): Jaundice</p><p><b>Postmarketing reports</b>: Abnormal liver function tests, hepatitis (some cases have been fatal)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Allergic reaction</p><p><b>Postmarketing reports</b>: Anaphylactic reaction/shock<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Hyponatremia, increased alkaline phosphatase, vitamin B12 deficiency, weight increase, weight decrease, anorexia, appetite increased</p><p><b>Postmarketing reports</b>: Hypomagnesemia with or without hypocalcemia</p><p></p><p>Naproxen:</p><p><b>Postmarketing reports</b>: Hyperglycemia, hypoglycemia<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Hypertonia, nervousness, hypoesthesia, impotence, insomnia, migraine, migraine aggravated, paresthesia, somnolence, tremor, taste loss</p><p><b>Postmarketing reports</b>: Hepatic encephalopathy, taste disturbance</p><p></p><p>Naproxen:</p><p><b>Common</b> (1% to 10%): Headache, dysgeusia, drowsiness, lightheadedness</p><p><b>Uncommon</b> (0.1% to 1%): Inability to concentrate</p><p><b>Postmarketing reports</b>: Cognitive dysfunction, convulsions<sup>[Ref]</sup></p><h3>Ocular</h3><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Visual field defect, conjunctivitis, vision abnormal</p><p><b>Postmarketing reports</b>: Blurred vision</p><p></p><p>Naproxen:</p><p><b>Common</b> (1% to 10%): Visual disturbances</p><p><b>Postmarketing reports</b>: Corneal opacity, papillitis, retrobulbar optic neuritis, papilledema<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Esomeprazole:</p><p><b>Uncommon</b> (0.1% to 1%): Sleep disorder, apathy, aggravated depression, confusion</p><p><b>Postmarketing reports</b>: Aggression, agitation, depression, hallucination</p><p></p><p>Naproxen:</p><p><b>Postmarketing reports</b>: Depression, dream abnormalities, insomnia<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. VIMOVO (esomeprazole-naproxen)." Astra-Zeneca Pharmaceuticals, Wilmington, DE. </p><h2>More about esomeprazole / naproxen</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>41 Reviews</li>
<li>Drug class: Nonsteroidal anti-inflammatory drugs</li>
<li>FDA Alerts (4)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Naproxen and esomeprazole &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Ankylosing Spondylitis</li>
<li>NSAID-Induced Ulcer Prophylaxis</li>
<li>Osteoarthritis</li>
<li>Rheumatoid Arthritis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>